US00370M1036
US00370M1036
Abivax S.A.(ADRs)
Loading chart...
Valuation & History
Quarterly trend of key valuation metrics
| Metric | Current (TTM) TTM Baseline | Q2 '26 30.06.2026 | Q1 '26 31.03.2026 | Q4 '25 31.12.2025 |
|---|---|---|---|---|
Market & Enterprise Value | ||||
Market Cap | 6.85B EUR | 9.26B EUR | 7.61B EUR | 9.35B EUR |
Enterprise Value | 5.9B EUR | 8.87B EUR | 7.14B EUR | 8.83B EUR |
Valuation Multiples | ||||
Trailing P/E | -- | -- | -- | -- |
Forward P/E | -- | -- | -- | -- |
Price to Sales | 1,467.61x | -- | -- | -- |
Price to Book | 17.11x | 25.28x | 17.72x | 20.53x |
EV/Revenue | 1,264.86x | -- | -- | -- |
EV/EBITDA | -20.25x | -- | -- | -- |
Price to FCF (P/FCF) | -- | -- | -- | -- |
EV/FCF | -- | -- | -- | -- |
FCF Yield | -1.84% | -2.13% | -2.35% | -1.37% |